ArticleFrontiers in transplantation2023

Post-transplant lymphoproliferative disorder risk and outcomes in renal transplant patients treated with belatacept immunosuppression.

Jean L Koff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.